News

RxAnte Achieves HITRUST CSF Certification, Upholding High Security Standards

Portland, ME. – November 2, 2016 – RxAnte, Inc., a leading predictive analytics and clinical services company, today announced it has achieved the Common Security Framework (CSF) Certified status from the Health Information Trust (HITRUST) Alliance. The HITRUST CSF is a certifiable framework that can be used by healthcare organizations and their business associates that create,…

RxAnte to Fuel Growth with Equity Investment from UPMC Enterprises; Millennium Health Sells Entire Interest in Analytics Company

PORTLAND, ME. – October 5, 2016 – RxAnte, a leading provider of solutions that improve the use of prescription medications, announced today that it has received a growth equity investment from UPMC Enterprises. Under the terms of the transaction closed on Sept. 30, Millennium Health sold its entire interest in RxAnte, which will continue to…

EnvisionInsurance Partnership with RxAnte Uses Predictive Technologies to Improve Care and Costs for Patients with Chronic Conditions

Portland, ME. – July 19, 2016 – RxAnte, LLC, the leading platform for improving medication use and drug therapy outcomes through predictive analytics, announced today that it is continuing its partnership with EnvisionInsurance, a national provider of Medicare Part D plans and a division of EnvisionRxOptions. Through this partnership, RxAnte uses data from large populations…

Horizon Healthcare Services, Inc. Selects RxAnte’s Analytic Solutions to Improve Medication Use

Portland, ME. – May 16, 2016 – RxAnte, LLC, the leading platform for improving medication use and drug therapy outcomes through predictive analytics and targeted clinical programs, today announced that it has renewed its collaboration with Horizon Healthcare Services, Inc., New Jersey’s oldest and largest insurer. RxAnte will provide its advanced analytics solutions to predict…

RxAnte Successfully Completes SOC 2 Type II Security Audit

Portland, ME. – March 22, 2016 – RxAnte, LLC, the leading platform for improving medication use and drug therapy outcomes through predictive analytics and targeted clinical programs, today announced it has received its Service Organization Control [SOC] 2 Type II attestation engagement report, providing independent validation that the Company’s security and confidentiality controls meet or…

AvMed Partners with RxAnte to Improve Medication Adherence

Arlington, Va. – Nov. 3, 2015 – RxAnte, LLC, the leading platform for improving medication use and drug therapy outcomes through predictive analytics and targeted clinical programs, today announced that AvMed, a leading Florida health plan and J.D. Power 2014 Customer Champion, has partnered with RxAnte. RxAnte’s advanced analytics platform will deliver population-level reporting and…

RxAnte Abstract Wins Gold Medal at AMCP Nexus 2015

Arlington, Va. – Oct. 27, 2015 – RxAnte, LLC, the leading platform for improving medication use and drug therapy outcomes through predictive analytics and targeted clinical programs, today announced The Academy of Managed Care Pharmacy® (AMCP) selected an RxAnte abstract as one of 25 gold medal winners at its annual fall conference, AMCP Nexus, in Orlando,…

RxAnte Introduces Subscription Analytics Services to Improve Medication Use

Arlington, Va. – Oct. 7, 2015 – RxAnte, LLC, the leading platform for improving medication use and drug therapy outcomes through predictive analytics and targeted clinical programs, today announced a new subscription analytics model that provides essential services to support health care organizations seeking to improve prescription medication use. The model includes population-level reporting and…

RxAnte Successfully Completes SOC 2 Type II Security Audit

Arlington, Va. – March 3, 2015 – RxAnte, LLC, the leading platform for improving medication use and drug therapy outcomes through predictive analytics and targeted clinical programs, today announced it has successfully undergone the necessary criteria to complete the Service Organization Control [SOC] 2 Type II audit addressing the security and confidentiality principles under the…

RxAnte Selected To Identify Medicare Members Eligible For WellCare’s MTM Program

RxAnte, Inc., a health care improvement company, and WellCare Health Plans, Inc. (NYSE: WCG), a leading provider of managed care services for government-sponsored health care programs, today announced that they have entered into an agreement under which WellCare will use RxAnte’s advanced analytics platform to identify existing Medicare members who are eligible for WellCare’s Medication Therapy Management (MTM) services.

RxAnte Launches Star Accelerator Program

In response to client demand, RxAnte announces the availability of the Star Accelerator TM Program. The program, specifically designed for Medicare Advantage and stand-alone Part D plans, offers a suite of services and tools proven to improve performance on the triple-weighted Part D Star Ratings measures in six months or less.

WellCare Extends Contract with RxAnte

In an announcement made today, RxAnte, Inc. revealed it has extended its contract with WellCare Health Plans, Inc., a managed care organization headquartered in Tampa, Fla., for an additional three years.

Robert Pfotenhauer Joins RxAnte Board of Directors

Today, RxAnte LLC, a health care predictive analytics and technology company that specializes in improving the use of prescription medications, announced Paul Tuten will join RxAnte’s leadership team as Vice President, Product Development and Management.